Hyperprolactinemia and male sexual function: focus on erectile dysfunction and sexual desire

G Corona, G Rastrelli, N Bianchi, C Sparano… - International Journal of …, 2023 - nature.com
The present paper aims to analyze and discuss the available evidence supporting the
relationship between male sexual function and elevated prolactin (PRL) levels (HPRL). Two …

Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?

DA Niculescu, ML Gheorghiu… - European Journal of …, 2023 - academic.oup.com
Radiotherapy, conventional or radiosurgery, has been used to control prolactin secretion
and tumour growth in prolactinomas both as part of multimodal therapy or rarely as primary …

The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of …

G Corona, D Cucinotta, G Di Lorenzo, A Ferlin… - Journal of …, 2023 - Springer
Purpose Erectile dysfunction (ED) is one of the most prevalent male sexual dysfunctions. ED
has been in the past mistakenly considered a purely psycho-sexological symptom by …

Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma …

LEH Bakker, MJT Verstegen, E Ghariq, BM Verbist… - Pituitary, 2022 - Springer
Purpose To report the first experience of our multidisciplinary team with functional imaging
using 11C-methionine positron emission tomography-computed tomography (11C …

Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases

M Korbonits, JC Blair, A Boguslawska, J Ayuk… - Nature Reviews …, 2024 - nature.com
Pituitary adenomas are rare in children and young people under the age of 19 (hereafter
referred to as CYP) but they pose some different diagnostic and management challenges in …

The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations

G Corona, G Rastrelli, P Comeglio… - Expert Review of …, 2022 - Taylor & Francis
Introduction Hyperprolactinemia has been proven to induce hypogonadism and metabolic
derangements in both genders, while the consequences of prolactin (PRL) deficiency have …

Treatment of prolactinoma

WJ Inder, C Jang - Medicina, 2022 - mdpi.com
Prolactinomas are the commonest form of pituitary neuroendocrine tumor (PitNET),
representing approximately half of such tumors. Dopamine agonists (DAs) have traditionally …

Reply to 'The shift of therapeutic strategy for prolactinomas: surgery as the first-line option'

S Petersenn, M Fleseriu, S Melmed - Nature Reviews Endocrinology, 2024 - nature.com
Consensus Statement. Nat. Rev. Endocrinol. 19, 722–740 (2023) 1) in their
Correspondence (Wu, ZB The shift of therapeutic strategy for prolactinomas: surgery as the …

Presurgical medical treatment in prolactinomas: surgical implications and pathological characteristics from 290 cases

Z Chen, X Shou, L Ji, H Cheng, M Shen… - The Journal of …, 2024 - academic.oup.com
Objective To review experience regarding the treatment of prolactinomas by endoscopic
endonasal surgery focusing on the association between presurgical dopamine agonist (DA) …

11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy

WA Bashari, M van der Meulen, J MacFarlane, D Gillett… - Pituitary, 2022 - Springer
Purpose To assess the potential for 11C-methionine PET (Met-PET) coregistered with
volumetric magnetic resonance imaging (Met-PET/MRCR) to inform clinical decision making …